Weight-loss jabs such as Ozempic could throw a lifeline to millions of people battling deadly liver disease - amid growing ...

A study led by UMass Chan researchers demonstrated that a gene therapy to correct a mutation that causes maple syrup urine ...

Altimmune's pemvidutide shows promise in treating MASH and obesity, with upcoming Phase 2b results poised to shape its market ...

The committee supports approving the CFTR modulator for patients 2 years and older with at least one non-class I CFTR gene mutation.

Reported unprecedented, statistically significant reversal of compensated cirrhosis (F4) due to MASH after 96 weeks of treatment with ...

The deadly non-alcoholic fatty liver disease is reaching epidemic proportions in India with 3 out of 10 adults and children ...

Solute carrier (SLC) family transporters are crucial transmembrane proteins responsible for transporting various molecules, ...

Dr. Makeda Dawkins shares expert insights on liver disease affecting African Americans, including risk factors, early warning signs, and prevention strategies.

At 2 years, participants in the compensated MASH cirrhosis treatment arm of the MAESTRO-NAFLD-1 trial experienced a ...

A modeling study predicts a substantial rise in MASLD prevalence and associated liver-related complications in the United ...

Liver disease is known as a ‘silent killer’ - and it's on the rise. We asked an expert how she keeps hers in good shape ...

Researchers from Medizinische Hochschule Hannover and affiliated organizations reported data from studies aimed to identify non-coding microRNAs (miRNAs) with therapeutic potential against liver ...